Ropivacaine infusion in diabetics subject with peripheral arterial diseasea prospective study

M. N D Di Minno; M. Milone; A. Russolillo; R. Lupoli; A. Di Minno; P. Maietta; C. Iacovazzo; G. Salvatore; F. Milone

doi:10.1055/s-0032-1327757

Ropivacaine infusion in diabetics subject with peripheral arterial diseasea prospective study

M. N D Di Minno, M. Milone, A. Russolillo, R. Lupoli, A. Di Minno, P. Maietta, C. Iacovazzo, G. Salvatore, F. Milone

Centro Cardiologico Monzino

Research output: Contribution to journal › Article

Abstract

Background: Peripheral arterial disease (PAD) predicts cardiovascular and cerebrovascular ischemic events. PAD treatment is aimed at reducing clinical symptoms, local tissue loss and at preventing complications. Aims:To evaluated the effect of peridural analgesia on peripheral perfusion and pain control. Methods: In 280 diabetic subjects with severe limb ischemia (65.7% males and 34.3% females, mean age 59.3±14.4 years) with a failure of medical treatment and contraindications to endovascular and/or surgical reperfusion, we performed a 30-day long peridural ropivacaine infusion, monitoring blood pressure, VAS and ABI periodically. Results: During ropivacaine infusion VAS significantly decreased (from 4.06±0.343 to 1.96±0.413, p

Original language	English
Pages (from-to)	91-93
Number of pages	3
Journal	Experimental and Clinical Endocrinology and Diabetes
Volume	121
Issue number	2
DOIs	https://doi.org/10.1055/s-0032-1327757
Publication status	Published - 2013

Fingerprint

Keywords

cardiovascular risk management
Diabetes
peripheral arterial disease

ASJC Scopus subject areas

Endocrinology
Endocrinology, Diabetes and Metabolism
Internal Medicine

Cite this

Di Minno, M. N. D., Milone, M., Russolillo, A., Lupoli, R., Di Minno, A., Maietta, P., Iacovazzo, C., Salvatore, G., & Milone, F. (2013). Ropivacaine infusion in diabetics subject with peripheral arterial diseasea prospective study. Experimental and Clinical Endocrinology and Diabetes, 121(2), 91-93. https://doi.org/10.1055/s-0032-1327757

@article{b0c38430760446faa512b835be09e99a,

title = "Ropivacaine infusion in diabetics subject with peripheral arterial diseasea prospective study",

abstract = "Background: Peripheral arterial disease (PAD) predicts cardiovascular and cerebrovascular ischemic events. PAD treatment is aimed at reducing clinical symptoms, local tissue loss and at preventing complications. Aims:To evaluated the effect of peridural analgesia on peripheral perfusion and pain control. Methods: In 280 diabetic subjects with severe limb ischemia (65.7% males and 34.3% females, mean age 59.3±14.4 years) with a failure of medical treatment and contraindications to endovascular and/or surgical reperfusion, we performed a 30-day long peridural ropivacaine infusion, monitoring blood pressure, VAS and ABI periodically. Results: During ropivacaine infusion VAS significantly decreased (from 4.06±0.343 to 1.96±0.413, p",

keywords = "cardiovascular risk management, Diabetes, peripheral arterial disease",

author = "{Di Minno}, {M. N D} and M. Milone and A. Russolillo and R. Lupoli and {Di Minno}, A. and P. Maietta and C. Iacovazzo and G. Salvatore and F. Milone",

year = "2013",

doi = "10.1055/s-0032-1327757",

language = "English",

volume = "121",

pages = "91--93",

journal = "Experimental and Clinical Endocrinology and Diabetes",

issn = "0947-7349",

publisher = "Thieme",

number = "2",

}

TY - JOUR

T1 - Ropivacaine infusion in diabetics subject with peripheral arterial diseasea prospective study

AU - Di Minno, M. N D

AU - Milone, M.

AU - Russolillo, A.

AU - Lupoli, R.

AU - Di Minno, A.

AU - Maietta, P.

AU - Iacovazzo, C.

AU - Salvatore, G.

AU - Milone, F.

PY - 2013

Y1 - 2013

N2 - Background: Peripheral arterial disease (PAD) predicts cardiovascular and cerebrovascular ischemic events. PAD treatment is aimed at reducing clinical symptoms, local tissue loss and at preventing complications. Aims:To evaluated the effect of peridural analgesia on peripheral perfusion and pain control. Methods: In 280 diabetic subjects with severe limb ischemia (65.7% males and 34.3% females, mean age 59.3±14.4 years) with a failure of medical treatment and contraindications to endovascular and/or surgical reperfusion, we performed a 30-day long peridural ropivacaine infusion, monitoring blood pressure, VAS and ABI periodically. Results: During ropivacaine infusion VAS significantly decreased (from 4.06±0.343 to 1.96±0.413, p

AB - Background: Peripheral arterial disease (PAD) predicts cardiovascular and cerebrovascular ischemic events. PAD treatment is aimed at reducing clinical symptoms, local tissue loss and at preventing complications. Aims:To evaluated the effect of peridural analgesia on peripheral perfusion and pain control. Methods: In 280 diabetic subjects with severe limb ischemia (65.7% males and 34.3% females, mean age 59.3±14.4 years) with a failure of medical treatment and contraindications to endovascular and/or surgical reperfusion, we performed a 30-day long peridural ropivacaine infusion, monitoring blood pressure, VAS and ABI periodically. Results: During ropivacaine infusion VAS significantly decreased (from 4.06±0.343 to 1.96±0.413, p

KW - cardiovascular risk management

KW - Diabetes

KW - peripheral arterial disease

UR - http://www.scopus.com/inward/record.url?scp=84874193956&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84874193956&partnerID=8YFLogxK

U2 - 10.1055/s-0032-1327757

DO - 10.1055/s-0032-1327757

M3 - Article

C2 - 23147211

AN - SCOPUS:84874193956

VL - 121

SP - 91

EP - 93

JO - Experimental and Clinical Endocrinology and Diabetes

JF - Experimental and Clinical Endocrinology and Diabetes

SN - 0947-7349

IS - 2

ER -

Access to Document

10.1055/s-0032-1327757